Corynebacterium striatum drives neutrophilic asthma via IL-17 signaling activation
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115255 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Xin Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. Electronic address: xyu23@mails.jlu.edu…. Hauptthemen laut MEDLINE: Asthma, Corynebacterium, Interleukin-17, Corynebacterium Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Corynebacterium striatum has recently been recognized as an emerging multidrug-resistant pathogen capable of causing both nosocomial and community-acquired infections, particularly in immunocompromised individuals and those with chronic conditions. However, direct evidence regarding the pathogenicity of C. striatum and its association with neutrophilic asthma remains poorly understood. In this study, a BALB/c mouse model infected with C. striatum was established at first to investigate its potential role in acute lung injury. The results demonstrated that C. striatum infection induced significant lung inflammation and pathological alterations, with more pronounced inflammatory responses observed in immunocompromised mice. Hematological analysis and fluorescence in situ hybridization (FISH) revealed a marked increase in neutrophil levels and confirmed the colonization of C. striatum in lung tissues. Furthermore, in an ovalbumin (OVA)-induced asthma model, C. striatum infection exacerbated neutrophilic inflammation and induced the significant upregulation of Interleukin (IL)-17, IL-6, and CXCL-8, alongside activation of the NF-κB signaling pathway. These findings suggest that C. striatum drives neutrophil recruitment and amplifies inflammatory responses by promoting a Th2/Th17 immune shift, highlighting the critical involvement of the IL-17 signaling pathway in C. striatum-associated asthma. This study provides novel experimental evidence supporting C. striatum as a respiratory pathogen and offers further theoretical rationale for targeting IL-17 in the treatment of C. striatum-related neutrophilic asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. Electronic address: xyu23@mails.jlu.edu.cn.
- Department of Laboratory Medicine, China-Japan Union Hospital of Jilin University, Changchun 130033, China. Electronic address: lixinyu1987@jlu.edu.cn.
- Department of Laboratory Medicine, China-Japan Union Hospital of Jilin University, Changchun 130033, China. Electronic address: wyb610895@mails.jlu.edu.cn.
- Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. Electronic address: yuxiao23@mails.jlu.edu.cn.
- Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. Electronic address: guoxp23@mails.jlu.edu.cn.
- Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. Electronic address: wangc19@mails.jlu.edu.cn.
Zitieren
APA
Yu, X., Li, X., Wang, Y., Yu, X., Guo, X., Wang, C., & Wang, F. (2025). Corynebacterium striatum drives neutrophilic asthma via IL-17 signaling activation. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115255
Vancouver
Yu X, Li X, Wang Y, Yu X, Guo X, Wang C, et al. Corynebacterium striatum drives neutrophilic asthma via IL-17 signaling activation. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115255
BibTeX
@article{Yu2025,
author = {Yu, Xin and Li, Xinyu and Wang, Yubo and Yu, Xiao and Guo, Xiaoping and Wang, Chao and Wang, Fang},
title = {Corynebacterium striatum drives neutrophilic asthma via IL-17 signaling activation},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115255}
}
EUVIMED